Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by guerreiroon Feb 10, 2011 1:56am

338 Views

Post# 18107249

Major accumulation by Canaccord

Some major investors must be behind the buying from Canaccord.

HBM's HLO position I believe is close to 7 million shares, perhaps more, and a large number of warrants to be exercised.

Does anyone have the actual number of shares and warrants owned by HBM. OR a complete break down of the share distribution positions. PNP, RBC, HBM.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments